# Cencora vs Edwards Lifesciences: stocks compared

URL: https://funkfolio.com/compare/cor-vs-ew

> Cencora ($66.9B, P/E 19.5) and Edwards Lifesciences ($60.6B, P/E 61.3) compared: size, valuation, margins, debt, cash and price change.

---

## Cencora vs Edwards Lifesciences

Cencora (COR), health care, and Edwards Lifesciences (EW), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Cencora is worth $66.9B on the stock market and Edwards Lifesciences $60.6B: Cencora is valued at 10% more. Cencora trades at 19.5 times earnings and Edwards Lifesciences at 61.3; operating margins in their latest fiscal years were 0.82% and 20.8%. Over the past year Cencora's share price has moved -1.30% and Edwards Lifesciences's +27.5%.

### Key facts

- **Cencora market value:** $66.9B
- **Edwards Lifesciences market value:** $60.6B
- **Cencora P/E:** 19.5
- **Edwards Lifesciences P/E:** 61.3
- **Cencora revenue:** $321.3B FY to 2025-09-30
- **Edwards Lifesciences revenue:** $6.1B FY to 2025-12-31
- **Superinvestors holding both:** 3

Market values as of 17 Nov 2026, 21:53 UTC.

Cencora vs Edwards Lifesciences: every measure side by side

| Measure | Cencora | Edwards Lifesciences |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-09-30 | 2025-12-31 |
| Size |  |  |
| Market cap | $66.9B higher | $60.6B lower |
| Revenue | $321.3B higher | $6.1B lower |
| Earnings | $1.6B higher | $1.1B lower |
| Employees | — | 16,000 |
| Total assets | $76.6B higher | $13.7B lower |
| Valuation |  |  |
| P/E | 19.5 lower | 61.3 higher |
| P/S | 0.2 lower | 10.0 higher |
| P/B | 18.2 higher | 5.6 lower |
| Dividend yield | 0.67% higher | 0.00% lower |
| Profitability |  |  |
| Operating margin | 0.82% lower | 20.8% higher |
| Balance sheet |  |  |
| Net assets | $1.5B lower | $10.3B higher |
| Total liabilities | $74.8B higher | $3.4B lower |
| Total debt | $7.7B higher | $598.3M lower |
| Cash on hand | $4.4B higher | $2.9B lower |
| Price change |  |  |
| Today | -1.79% lower | -1.57% higher |
| 1 year | -1.30% lower | +27.5% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Cencora 96.0, Edwards Lifesciences 124.4.

- Cencora (COR)
- Edwards Lifesciences (EW)

Cencora and Edwards Lifesciences share prices over one year, rebased to 100: Cencora ends at 96.0, Edwards Lifesciences at 124.4.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | COR | EW |
| --- | --- | --- |
| Nov 28, 2025 | 101.1 | 102.3 |
| Dec 31, 2025 | 92.5 | 100.6 |
| Jan 30, 2026 | 98.4 | 96.0 |
| Feb 27, 2026 | 102.0 | 102.0 |
| Mar 31, 2026 | 86.1 | 94.5 |
| Apr 30, 2026 | 84.4 | 98.5 |
| May 29, 2026 | 73.8 | 102.0 |
| Jun 30, 2026 | 77.5 | 106.8 |
| Jul 31, 2026 | 85.3 | 101.6 |
| Aug 31, 2026 | 88.7 | 107.1 |
| Sep 30, 2026 | 82.3 | 101.9 |
| Oct 30, 2026 | 90.6 | 108.6 |
| Nov 17, 2026 | 96.0 | 124.4 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (3)

- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.3% / 0.2%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.2% / 0.2%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.2% / 0.2%

#### Cencora only (0)

None of the tracked investors.

#### Edwards Lifesciences only (6)

- [David Rolfe](https://funkfolio.com/gurus/david-rolfe) 3.1%
- [Howard Gleicher](https://funkfolio.com/gurus/howard-gleicher) 1.6%
- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 0.7%
- [Primecap team](https://funkfolio.com/gurus/primecap) 0.2%
- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 0.1%
- [Ron Baron](https://funkfolio.com/gurus/ron-baron) 0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Cencora / Edwards Lifesciences). [Who owns COR](https://funkfolio.com/stock/COR/superinvestors) · [Who owns EW](https://funkfolio.com/stock/EW/superinvestors)

### More on Cencora

- [Cencora (COR) stock page](https://funkfolio.com/stock/COR)
- [Cencora market cap](https://funkfolio.com/stock/COR/market-cap)
- [Cencora revenue](https://funkfolio.com/stock/COR/revenue)
- [Cencora P/E ratio](https://funkfolio.com/stock/COR/pe-ratio)
- [Cencora operating margin](https://funkfolio.com/stock/COR/operating-margin)
- [Cencora total debt](https://funkfolio.com/stock/COR/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Edwards Lifesciences

- [Edwards Lifesciences (EW) stock page](https://funkfolio.com/stock/EW)
- [Edwards Lifesciences market cap](https://funkfolio.com/stock/EW/market-cap)
- [Edwards Lifesciences revenue](https://funkfolio.com/stock/EW/revenue)
- [Edwards Lifesciences P/E ratio](https://funkfolio.com/stock/EW/pe-ratio)
- [Edwards Lifesciences operating margin](https://funkfolio.com/stock/EW/operating-margin)
- [Edwards Lifesciences total debt](https://funkfolio.com/stock/EW/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Cencora against its closest peers

- [Cencora vs Takeda Pharmaceutical](https://funkfolio.com/compare/cor-vs-tak)
- [Cencora vs Boston Scientific](https://funkfolio.com/compare/bsx-vs-cor)
- [Cencora vs Cardinal Health](https://funkfolio.com/compare/cah-vs-cor)
- [Cencora vs argenx](https://funkfolio.com/compare/argx-vs-cor)

#### Edwards Lifesciences against its closest peers

- [Edwards Lifesciences vs argenx](https://funkfolio.com/compare/argx-vs-ew)
- [Edwards Lifesciences vs Becton, Dickinson](https://funkfolio.com/compare/bdx-vs-ew)
- [Edwards Lifesciences vs Cardinal Health](https://funkfolio.com/compare/cah-vs-ew)
- [Edwards Lifesciences vs Boston Scientific](https://funkfolio.com/compare/bsx-vs-ew)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Cencora or Edwards Lifesciences?**

By market value, Cencora is the larger: $66.9B against $60.6B for Edwards Lifesciences. By revenue in its latest fiscal year, Cencora is the larger: $321.3B against $6.1B for Edwards Lifesciences.

**Which has the higher P/E ratio?**

Edwards Lifesciences: 61.3, against 19.5 for Cencora. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

Edwards Lifesciences: 20.8%, against 0.82% for Cencora. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

Cencora: 0.67%, against 0.00% for Edwards Lifesciences. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

Cencora: $7.7B, against $598.3M for Edwards Lifesciences. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Cencora and Edwards Lifesciences?**

In their latest 13F filings, Steve Cohen, Ken Griffin and Israel Englander hold both.

### Cite this page

Funkfolio, “Cencora vs Edwards Lifesciences”, data as of 17 November 2026. https://funkfolio.com/compare/cor-vs-ew

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
